214 related articles for article (PubMed ID: 21855185)
1. Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?
Scheede-Bergdahl C; Watt HL; Trutschnigg B; Kilgour RD; Haggarty A; Lucar E; Vigano A
Clin Nutr; 2012 Feb; 31(1):85-8. PubMed ID: 21855185
[TBL] [Abstract][Full Text] [Related]
2. Steep elevation of blood interleukin-6 (IL-6) associated only with late stages of cachexia in cancer patients.
Iwase S; Murakami T; Saito Y; Nakagawa K
Eur Cytokine Netw; 2004; 15(4):312-6. PubMed ID: 15627639
[TBL] [Abstract][Full Text] [Related]
3. Elevation of cytokine levels in cachectic patients with prostate carcinoma.
Pfitzenmaier J; Vessella R; Higano CS; Noteboom JL; Wallace D; Corey E
Cancer; 2003 Mar; 97(5):1211-6. PubMed ID: 12599227
[TBL] [Abstract][Full Text] [Related]
4. Impact of weight loss on circulating IL-1, IL-6, IL-8, TNF-alpha, VEGF-A, VEGF-C and midkine in gastroesophageal cancer patients.
Krzystek-Korpacka M; Matusiewicz M; Diakowska D; Grabowski K; Blachut K; Kustrzeba-Wojcicka I; Banas T
Clin Biochem; 2007 Dec; 40(18):1353-60. PubMed ID: 17931612
[TBL] [Abstract][Full Text] [Related]
5. Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia.
Burney BO; Hayes TG; Smiechowska J; Cardwell G; Papusha V; Bhargava P; Konda B; Auchus RJ; Garcia JM
J Clin Endocrinol Metab; 2012 May; 97(5):E700-9. PubMed ID: 22419719
[TBL] [Abstract][Full Text] [Related]
6. [Cytokines in experimental cancer cachexia].
Niu Q; Li T; Liu A
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):382-4. PubMed ID: 11810767
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of tumour necrosis factor-alpha and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate--preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapy.
Grim-Stieger M; Keilani M; Mader RM; Marosi C; Schmidinger M; Zielinski CC; Fialka-Moser V; Crevenna R
Eur J Cancer Care (Engl); 2008 Sep; 17(5):454-62. PubMed ID: 18637115
[TBL] [Abstract][Full Text] [Related]
8. Lipolysis--not inflammation, cell death, or lipogenesis--is involved in adipose tissue loss in cancer cachexia.
Rydén M; Agustsson T; Laurencikiene J; Britton T; Sjölin E; Isaksson B; Permert J; Arner P
Cancer; 2008 Oct; 113(7):1695-704. PubMed ID: 18704987
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory markers and loss of muscle mass (sarcopenia) and strength.
Schaap LA; Pluijm SM; Deeg DJ; Visser M
Am J Med; 2006 Jun; 119(6):526.e9-17. PubMed ID: 16750969
[TBL] [Abstract][Full Text] [Related]
10. Serum cytokines and cancer in involuntary weight loss.
Baicus C; Caraiola S; Rimbas M; Patrascu R; Baicus A;
J Investig Med; 2012 Jun; 60(5):827-9. PubMed ID: 22481167
[TBL] [Abstract][Full Text] [Related]
11. [Effects of lactone I from Atractylodes macrocephala Koidz on cytokines and proteolysis-inducing factors in cachectic cancer patients].
Liu Y; Ye F; Qiu GQ; Zhang M; Wang R; He QY; Cai Y
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1308-11. PubMed ID: 16234118
[TBL] [Abstract][Full Text] [Related]
12. [Serum ghrelin, IL-6 and TNF-α levels in patients with chronic obstructive pulmonary disease.].
Deveci Y; Deveci F; Ilhan N; Karaca I; Turgut T; Muz MH
Tuberk Toraks; 2010; 58(2):162-72. PubMed ID: 20865569
[TBL] [Abstract][Full Text] [Related]
13. Plasma cytokines as markers of aseptic prosthesis loosening.
Hundrić-Haspl Z; Pecina M; Haspl M; Tomicic M; Jukic I
Clin Orthop Relat Res; 2006 Dec; 453():299-304. PubMed ID: 16906105
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study.
de Raaf PJ; Sleijfer S; Lamers CH; Jager A; Gratama JW; van der Rijt CC
Cancer; 2012 Dec; 118(23):6005-11. PubMed ID: 22736424
[TBL] [Abstract][Full Text] [Related]
15. Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients.
Fortunati N; Manti R; Birocco N; Pugliese M; Brignardello E; Ciuffreda L; Catalano MG; Aragno M; Boccuzzi G
Oncol Rep; 2007 Dec; 18(6):1521-7. PubMed ID: 17982639
[TBL] [Abstract][Full Text] [Related]
16. Can the interleukin-1 receptor antagonist (IL-1ra) be a marker of anti-inflammatory response to enteral immunonutrition in malnourished patients after pancreaticoduodenectomy?
Slotwinski R; Olszewski WL; Slotkowski M; Lech G; Zaleska M; Slotwinska SM; Krasnodebski WI
JOP; 2007 Nov; 8(6):759-69. PubMed ID: 17993728
[TBL] [Abstract][Full Text] [Related]
17. The relationship between interleukin-6, tumor necrosis factor-α, and fatigue in terminally ill cancer patients.
Kwak SM; Choi YS; Yoon HM; Kim DG; Song SH; Lee YJ; Yeom CH; Koh SJ; Park J; Lee MA; Suh SY
Palliat Med; 2012 Apr; 26(3):275-82. PubMed ID: 21807751
[TBL] [Abstract][Full Text] [Related]
18. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients.
Kayacan O; Karnak D; Beder S; Güllü E; Tutkak H; Senler FC; Köksal D
Am J Clin Oncol; 2006 Aug; 29(4):328-35. PubMed ID: 16891858
[TBL] [Abstract][Full Text] [Related]
19. The relationship among acute-phase responce proteins, cytokines, and hormones in various gastrointestinal cancer types patients with cachectic.
Kemik O; Kemik AS; Begenik H; Erdur FM; Emre H; Sumer A; Purisa S; Tuzun S; Kotan C
Hum Exp Toxicol; 2012 Feb; 31(2):117-25. PubMed ID: 21803781
[TBL] [Abstract][Full Text] [Related]
20. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.
Martignoni ME; Kunze P; Hildebrandt W; Künzli B; Berberat P; Giese T; Klöters O; Hammer J; Büchler MW; Giese NA; Friess H
Clin Cancer Res; 2005 Aug; 11(16):5802-8. PubMed ID: 16115919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
